Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $43,034 - $51,469
-4,282 Reduced 29.94%
10,020 $106,000
Q1 2024

May 10, 2024

SELL
$11.27 - $13.53 $189,843 - $227,912
-16,845 Reduced 54.08%
14,302 $171,000
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $89,024 - $110,138
-10,151 Reduced 24.58%
31,147 $336,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $50,069 - $59,258
-5,221 Reduced 11.22%
41,298 $407,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $141,253 - $161,141
-15,660 Reduced 25.19%
46,519 $465,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $23,579 - $31,422
-2,563 Reduced 3.96%
62,179 $598,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $99,512 - $131,922
-11,412 Reduced 14.99%
64,742 $720,000
Q3 2022

Nov 10, 2022

SELL
$8.48 - $11.13 $23,074 - $30,284
-2,721 Reduced 3.45%
76,154 $649,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $73,669 - $90,847
-7,404 Reduced 8.58%
78,875 $825,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $21,032 - $33,017
2,144 Added 2.55%
86,279 $940,000
Q4 2021

Feb 15, 2022

SELL
$12.09 - $14.68 $193,681 - $235,173
-16,020 Reduced 16.0%
84,135 $1.14 Million
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $156,217 - $178,382
11,790 Added 13.34%
100,155 $1.36 Million
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $93,059 - $115,876
-7,175 Reduced 7.51%
88,365 $1.26 Million
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $829,574 - $1.13 Million
61,043 Added 176.95%
95,540 $1.34 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $493,307 - $646,473
34,497 New
34,497 $646,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.